Expertise in
28
conditions

Dr. Sandeep K. Bansal

Cardiology
217 Harrisburg Avenue, 
Lancaster, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
28
conditions
217 Harrisburg Avenue, 
Lancaster, PA 

Overview

Sandeep Bansal is a Cardiologist practicing medicine in Lancaster, Pennsylvania.

Dr. Bansal is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Arrhythmogenic Right Ventricular Cardiomyopathy, Pacemaker Implantation, and Cardiac Ablation.

Dr. Bansal is board certified in Clinical Cardiac Electrophysiology, 2012 and Cardiovascular Disease, 2010. He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 13 clinical trials. Dr. Bansal is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in PA

Board Certifications

Clinical Cardiac Electrophysiology, 2012
Cardiovascular Disease, 2010

Fellowships

Massachusetts General Hospital/Brigham and Women’s Hospital
Johns Hopkins Hospital

Hospital Affiliations

Hospital Of Univ Of Pennsylvania
Lancaster General Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

The Heart Group of Lancaster General Health
217 Harrisburg Avenue, Lancaster, PA 17603

Additional Areas of Focus

Dr. Bansal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Paroxysmal Supraventricular Tachycardia (PSVT)
Mitral Valve Regurgitation
Hypertension
Sick Sinus Syndrome
Endocarditis
Giant Cell Myocarditis
Heart Murmurs
Pericarditis
Pulmonary Edema
Mitral Valve Prolapse
Fainting
Atrial Septal Defect (ASD)
Patent Foramen Ovale
Heart Failure
Atherosclerosis
Cardiomyopathy
Pulmonary Valve Stenosis
Aortic Valve Stenosis
View 8 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Needle-Based Confocal Laser Endomicroscopy to Aid in Lung Nodule Localization by Robotic-Assisted Navigational Bronchoscopy
Needle-Based Confocal Laser Endomicroscopy to Aid in Lung Nodule Localization by Robotic-Assisted Navigational Bronchoscopy
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Device
Study Phase: Not Applicable
Evaluating MRI Scanning in Patients With Fractured or Abandoned Endocardial Leads
Evaluating MRI Scanning in Patients With Fractured or Abandoned Endocardial Leads
Enrollment Status: Terminated
Publish Date: September 16, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Zephyr Valve Registry
Zephyr Valve Registry
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Device
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Device
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 9 Less Clinical Trials

29 Total Publications

Comparative Efficacy of Continuous Versus Patch ECG Monitoring in Detecting Atrial Fibrillation Recurrence Post Catheter Ablation: Insights From the REAL-AF Registry.
Comparative Efficacy of Continuous Versus Patch ECG Monitoring in Detecting Atrial Fibrillation Recurrence Post Catheter Ablation: Insights From the REAL-AF Registry.
Journal: Journal of cardiovascular electrophysiology
Published: March 03, 2026
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
Before you request

The Heart Group Of Lancaster General Health

217 Harrisburg Avenue, 
Lancaster, PA 
 (0.1 miles away)
717-544-8300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Arkles is a Cardiologist practicing medicine in Lancaster, Pennsylvania. Dr. Arkles is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Arkles is board certified in Clinical Cardiac Electrophysiology, 2014 and Cardiovascular Disease, 2013. Dr. Arkles is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center Radnor

145 King Of Prussia Road, Floor 1, Suite 110 South, 
Radnor, PA 
 (50.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Francis Marchlinski is a Cardiologist practicing medicine in Radnor, Pennsylvania. Dr. Marchlinski is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Marchlinski is board certified in Cardiovascular Disease, 1981, Clinical Cardiac Electrophysiology, 1992, and Internal Medicine, 1979. Dr. Marchlinski is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center Radnor

145 King Of Prussia Road, Floor 1, Suite 110 South, 
Radnor, PA 
 (50.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Frankel is a Cardiologist practicing medicine in Radnor, Pennsylvania. Dr. Frankel is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation. Dr. Frankel is board certified in Clinical Cardiac Electrophysiology, 2011. Dr. Frankel is currently accepting new patients.

Frequently Asked Questions about Dr. Sandeep K. Bansal

How do I make an appointment with Dr. Sandeep K. Bansal?

You can book an appointment with Dr. Sandeep K. Bansal by calling their office at 717-544-8300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sandeep K. Bansal a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sandeep K. Bansal is classified as an Distinguished expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sandeep K. Bansal specialize in?

While Dr. Sandeep K. Bansal is a Cardiology, they have specific expertise in Atrial Fibrillation, Arrhythmias, and Arrhythmogenic Right Ventricular Cardiomyopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Sandeep K. Bansal participate in research or clinical trials?

Yes. Dr. Sandeep K. Bansal has published 29 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Dr. Sandeep K. Bansal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sandeep K. Bansal accept my insurance?

Dr. Sandeep K. Bansal accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 717-544-8300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bansal's expertise for a condition
ConditionClose
    View All 18 Distinguished Conditions
    View All 10 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile